D

DND PharmaTech Inc
KOSDAQ:347850

Watchlist Manager
DND PharmaTech Inc
KOSDAQ:347850
Watchlist
Price: 92 300 KRW 2.1% Market Closed
Market Cap: 4T KRW

Net Margin
DND PharmaTech Inc

-397.6%
Current
-398%
Average
-6.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-397.6%
=
Net Income
-37.1B
/
Revenue
9.3B

Net Margin Across Competitors

No Stocks Found

DND PharmaTech Inc
Glance View

Market Cap
4T KRW
Industry
Biotechnology

DND PharmaTech Inc is a KR-based company operating in Biotechnology industry. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2024-05-02. DND Pharmatech Inc is a Korea-based clinical-stage biotech company mainly engaged in the research and development in medicines. The firm's product pipeline mainly focuses on indications including metabolic disease, neurodegenerative and fibrotic diseases. In addition, the Company is engaged in the research and development of therapeutic medicines used for diabetes, obesity and nonalcoholic steatohepatitis as well as others.

Intrinsic Value
1 952.84 KRW
Overvaluation 98%
Intrinsic Value
Price
D
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-397.6%
=
Net Income
-37.1B
/
Revenue
9.3B
What is the Net Margin of DND PharmaTech Inc?

Based on DND PharmaTech Inc's most recent financial statements, the company has Net Margin of -397.6%.

Back to Top